Shares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given an average rating of “Buy” by the six research firms that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $15.80.
Several brokerages have recently issued reports on ANNX. Needham & Company LLC reaffirmed a “buy” rating and issued a $16.00 price target on shares of Annexon in a research report on Tuesday, March 4th. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 price target on shares of Annexon in a research report on Tuesday, December 17th.
View Our Latest Stock Analysis on ANNX
Institutional Inflows and Outflows
Annexon Price Performance
Annexon stock opened at $2.75 on Thursday. The company has a market capitalization of $301.70 million, a price-to-earnings ratio of -2.62 and a beta of 1.14. Annexon has a one year low of $2.30 and a one year high of $8.40. The company’s fifty day moving average price is $3.44 and its two-hundred day moving average price is $5.19.
Annexon (NASDAQ:ANNX – Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05). As a group, sell-side analysts anticipate that Annexon will post -0.96 earnings per share for the current year.
Annexon Company Profile
Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.
Read More
- Five stocks we like better than Annexon
- What is Insider Trading? What You Can Learn from Insider Trading
- Can TikTok Stock Picks Really Make You Rich?
- How to start investing in penny stocks
- The “Quality” Rotation: Back to Basics Investing
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Annexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Annexon and related companies with MarketBeat.com's FREE daily email newsletter.